PET/CT colonography could provide 'all-in-one' staging
Integrated fused imaging detects polyps found with optical colonoscopy as well as extracolonic tumors
Researchers have found success integrating whole-body PET/CT tumor, lymph node, and metastasis staging with CT colonography in one exam. The technique provided accurate results for TNM staging in patients with colorectal cancer.
The CT colonography adds only seven minutes to the exam, which might be shortened with newer protocols, according to Dr. Patrick Veit, a radiologist now at University Hospital Zurich in Switzerland.
Veit and former colleagues from University Hospital Essen in Germany presented a study of 14 patients at the 2006 European Congress of Radiology. A study with more patients is currently under review. Patients undergo whole-body PET/CT after water-based bowel distention and pharmacological bowel relaxation. Histopathology from conventional colonoscopy, as well as surgical histopathology, serves as the standard of reference. Radiologists use 3D primary reading for all exams.
In the study of 14 patients, PET/CT colonography revealed 18 of 19 colonic lesions detected by conventional colonoscopy; only one flat lesion was missed. Six extracolonic tumor sites were detected with the integrated PET/CT exam. Based on the imaging findings, 11 patients were treated surgically, while three received chemotherapy. For the surgically treated patients, PET/CT revealed correct T-stage in eight patients and correct N-stage in nine patients.
"Whole-body PET/CT with integrated CT colonography might be used as an all-in-one staging procedure, especially in patients with incomplete colonoscopy," Veit said.
A future endeavor would be trying new tracers, such as one that indicates hypoxia that could be used for neoadjuvant downstaging, he said.
Can MRI-Guided Transurethral Ultrasound Ablation Have an Impact for Localized Prostate Cancer?
December 11th 2023Follow-up MRI imaging one year after transurethral ultrasound ablation revealed approximately 50 percent decreases in prostate volume and median PSA density, according to recently presented research findings at the 2023 Society of Urologic Oncology (SUO) Annual Meeting.
What a New Mammography Study Reveals About BMI, Race, Ethnicity and Advanced Breast Cancer Risk
December 8th 2023In a new study examining population attributable risk proportions (PARPs) based on data from over three million screening mammography exams, researchers found that postmenopausal Black women had the highest BMI-related PARP and premenopausal Asian and Pacific Islander women had the highest breast density-related PARP for advanced breast cancer.
Study: Contrast-Enhanced Mammography Changes Surgical Plan in 22.5 Percent of Breast Cancer Cases
December 7th 2023Contrast-enhanced mammography detected additional lesions in 43 percent of patients and led to additional biopsies in 18.2 percent of patients, over half of whom had malignant lesions, according to a study of over 500 women presented at the recent Radiological Society of North America (RSNA) conference.
What a New Study Reveals About Adjunctive DBT and Early-Stage Invasive Breast Cancer
December 6th 2023The combination of digital breast tomosynthesis (DBT) and digital mammography had a 21.6 higher invasive breast cancer detection rate for stage 1 tumors than digital mammography alone, according to a new study involving nearly 100,000 women.
